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Enhancement of vascular action of arginine vasopressin by diminished
extracellular sodium concentration. The present study was undertaken
to examine the effects of diminished extracellular sodium concentration
on the vascular action of arginine vasopressin (AVP) in cultured rat
vascular smooth muscle cells (VSMC). The preincubation of cells with
the 110 mat extracellular Na ([Na]e) solution supplemented with 30
mat choline chloride for 60 minutes enhanced the effect of AVP- (1 x
10—8 M) induced VSMC contraction. The treatment of 110 mat [Na4]
solution also enhanced the cellular contractile response to the protein
kinase C (PKC) activators, phorbol 12-myristate 13-acetate and I-ole-
oyl-2-acetyl-glycerol. Furthermore, preincubation with the 110 mM
[Na]e solution also potentiated the effect of I x 10—8 at AVP, but not
1 x 10—6 M, to increase the cytosolic-free Ca2 ([Ca24]1) concentration.
The 110 mat [Na]e media decreased the basal intracellular Na
concentration and increased intracellular 45Ca2 accumulation, basal
[Ca24]1 and AVP-produced 45Ca24 efflux. These effects of 110 mM
[Na4]e solution to enhance the vascular action of AVP were abolished
by using Ca2-free 110 mat [Na4]e solution during the preincubation
period. The preincubation with the 110 mat [Na4] solution did not
change either the Kd and Bmax of AVP V1 receptor of VSMC or the
AVP-induced production of inositol I ,4,5-trisphosphate. The present in
vitro results therefore indicate that the diminished extracellular fluid
sodium concentration within a range observed in clinical hyponatremic
states enhances the vascular action of AVP. The mechanism of this
effect appears to be mediated by a potentiation of the AVP-induced
increase in [Ca24]1 and enhanced activity of PKC secondary to an
increase in the cellular Ca2 uptake.
Several important clinical states such as congestive heart
failure [1—31, cirrhosis [4, 5], mineralocorticoid [6—8] or glu-
cocorticoid deficiency [9, 10], hypothyroidism [11], and extra-
cellular fluid sodium depletion [12] may be associated with the
non-osmotic release of arginine vasopressin (AVP) and hy-
ponatremia. This non-osmotic release of AVP has been pro-
posed to constitute an important component, along with the
renin-angiotensin-aldosterone axis and the sympathetic nervous
system, of the vascular response to maintain arterial circulatory
integrity in these various hyponatremic states [13, 14]. Evi-
dence in support of this hypothesis has been obtained by the
demonstration of a vascular effect of AVP in circumstances of
adrenal insufficiency [8], sodium restriction [12], and congestive
heart failure [2, 3] by using a specific antagonist to the vascular
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effect of AVP. Even though the extracellular to intracellular
Na4 concentration gradient is known to alter Ca2 uptake in
vascular smooth muscle cells (VSMC) [15—17], the potential
effect of a diminution in extracellular Na4 concentration, in the
range observed in hyponatremic states, on the vascular action
of AVP has not heretofore been studied.
The present in vitro study was therefore undertaken to
examine whether the reduction of extracellular Na4 concentra-
tion ([Na]e) within a clinical range enhances the AVP-induced
cellular contractile response in rat VSMC. The cellular mech-
anisms of 110 mat [Na4]e solution made isotonic with choline to
enhance the vascular action of AVP were therefore studied by
examining the AVP-induced increase in cytosolic-free Ca24
([Ca24]1) and the transmembrane Ca24 movement, the AVP
receptor binding, and the AVP-stimulated inositol phosphate
production. The possible role of protein kinase C (PKC) in the
mechanism of 110 mat [Nale to enhance the vascular action of
AVP was also studied by examining the effect of 110 mat [Na4]e
on the cellular contractile response to the PKC activators,
phorbol 12-myristate 13-acetate (PMA) and 1-oleoyl-2-acetyl-
glycerol (OAG).
Methods
Cell culture
Rat VSMC were isolated using the method of our previous
studies [18—21]. Briefly, the rat thoracic aortas were dissected
from 8 to 10 male Sprague-Dawley rats (200 to 300 g) and then
incubated in Eagle's minimum essential medium (MEM)
(Gibco, Grand Island, New York, USA) containing 2 mg/mI
collagenase (Worthington Biochemicals, Freehold, New Jer-
sey, USA) for one hour at 37°C. After the removal of adventitia
and small fragments of the outer membrane, the aortas were
minced and further incubated in Eagle's MEM containing 2
mg/mI collagenase for two hours at 37°C. The freshly isolated
cells were resuspended in Eagle's MEM containing 1 LM
L-glutamine (Sigma, St. Louis, Missouri, USA), 100 U/mI
penicillin and 100 pg/mI streptomycin (Gibco) and 10% fetal
bovine serum (Hazieton Research Products, Inc., Lenexa,
Kansas, USA). The cells were kept in a humidified incubator
under 95% air/5% CO2 at 37°C. All of the experiments except
the cell contraction studies were done in subcultured cells
within the fourth passage. The subculture was performed by
0.25% trypsin treatment. Cells grown on thin glass slides (13
mm in diameter; Fisher Scientific, Englewood, Colorado, USA)
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were used for the measurement of [Ca2]1 and intracellular Na
concentration ([Na]). The monolayer cells on 35 x 10 mm
plastic dishes were used to perform the studies of 45Ca2
accumulation and 45Ca2 efflux, the AVP receptor analysis and
the measurement of intracellular inositol phosphate.
Study ofcellular contractile response
The cellular contractile response was assessed by quantita-
tion of cell surface area changes using phase-contrast micros-
copy (IM, Zeiss, Germany) and a digital imaging analysis
system (Zidas, Zeiss). This method of morphometric analysis is
similar to the method reported from our and other laboratories
[18—22]. The cellular contractile studies were performed six to
eight days after seeding the primary cultures. The magnitude of
the shape change response was determined by comparing
groups of 14 to 20 cells. The measurements of cell surface area
were performed in triplicate. The cells were washed twice with
2 ml physiological saline solution [PSS, in mM: 140 NaC1, 4.6
KCI, 1.0 MgC12, 2.0 CaCI2, 10 glucose, and 10 N-2-hydroxyeth-
ylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.4] before
the first measurement of cell surface area. To evaluate the effect
of 110 mrvi [Na]e on basal VSMC contraction, the second
measurement of cell surface area was performed after the cells
were incubated for 60 minutes with PSS or 110 mM [Na1e
solution (in mM: 110 NaC1, 4.6 KC1, 1.0 MgCI2, 2.0 CaC12, 10
glucose, and 10 HEPES, pH 7.4, adjusted by Tris-base) sup-
plemented with 30 m choline chloride for the maintenance of
osmolality. To examine the effects of 110 msi [Na]e on the
AVP-, PMA- or OAG-induced cellular contractile response, the
third measurement of cell surface area was done after a 10
minute incubation at 37°C with PSS or 110mM [Na1e solution
in the presence or absence of AVP (Sigma), PMA (Sigma) or
OAG (Sigma). The cells with more than a 10% decrease in cell
surface area between the first and the second measurement or
between the second and the third measurement were consid-
ered the contractile cells. The results are expressed as the
percent of total cells.
Measurement of[Ca2]1
The experimental procedure to measure [Ca2J1 was similar
to that used in our previous studies [18, 19, 21]. The cultured
VSMC were rinsed twice with PSS or 110 mM [Na]e solution
and incubated with PSS or 110 mi [Na]e solution containing 4
LM fura2/AM (Molecular Probes, Inc., Eugene, Oregon, USA)
for 60 minutes at 37°C. At the end of the loading period, the
cells were washed twice with PSS or 110 mii [Na]e solution
and the coverslips were inserted into a quartz duvette with 3 ml
PSS or 110mM [Na]e solution. The fluorescent intensity of the
fura2 loaded cells was measured using a Perkin-Elmer fluores-
cence spectrophotometer (Model 650-lOS, Norwalk, Connecti-
cut, USA) equipped with a thermostatically controlled cuvette
holder. The fluorescence of fura2 was measured using two
excitation wavelengths, 345 and 380 nm (5 nm slit), and a 500
nm (5 nm slit) emission wavelength. The ratios of the emitted
fluorescence signals at the two excitation wavelengths permit-
ted the calculation of the [Ca2] concentration independent of
cell number, dye loading conditions and dye bleaching. The
autofluorescence was measured in similar cells which had not
been loaded with fura2 and was below 10% of the total
fluorescence of fura2 loaded cells. After the subtraction of
autofluorescence for each wavelength, the [Ca211 concentra-
tion was calculated using the method of Grynkiewicz, Poenie
and Tsien [23]; Rmax and Rmin were determined by treating the
cells with 5 X l0— M digitonin and 1 x 102 M ethyleneglycol-
bis (3-aminoethylether)-N,N'-tetraacetic acid (EGTA), respec-
tively.
Measurement of[Na],
The rat VSMC were rinsed twice with PSS or 110 mr'i [Na]e
solution and were incubated with PSS containing 10 M Na-
binding benzofuran isophthalate acetoxymethyl ester (SBFI/
AM; Molecular Probes) for three hours at 37°C [20, 24—26].
SBFI/AM was dissolved in PSS containing 0.02% pluonic
F-127, a non-ionic surfactant. After the loading period, the cells
on glass slides were rinsed with PSS and then placed in a quartz
cuvette at 37°C in a fluorescence spectrophotometer (CAF-100;
Japan Spectrometer, Tokyo, Japan). The complete hydrolysis
of SBFI/AM to SBFI was judged by changes in the excitation
and emission spectra. The dual-wavelength excitation method
for the measurement of SBFI fluorescence was used. The
fluorescence of SBFI was monitored at 500 nm with excitation
wavelengths of 340 and 380 nm in the ratio mode. [Na] was
calibrated by equilibrating [Na]1 with the [Naie concentration
using 1 x 106 M gramicidin. The reference standard solution
was made from appropriate mixtures of Na and K, which
were adjusted to 135 m (total Na + K). The [Na], was
determined from the relationship between the ratio and the
authentic [Na]1 [20, 24, 25].
Intracellular 45Ca2 uptake
The cells were washed twice with 2.0 ml PSS and incubated
with 1.0 ml PSS or 100 mrvi [Na]e solution containing 1 j.tCi/ml
45Ca2 + (specific activity, 12.3 mCi/mg Ca2; ICN Radiochem-
icals, Irvine, California, USA) at 37°C for different times (1, 5,
10, 30, and 60 mm). The cells were also incubated with 1.0 mM
PSS or different concentrations of [Nai solution (110, 80, 40,
and 0 mM) supplemented with choline chloride for 60 minutes at
37°C. After the incubation period, external 45Ca2 was removed
by rinsing the dish three times with 2.0 ml ice-cold Ca2-free
PSS containing 1.0 mri EGTA. The cells were treated with
hypotonic shock by the addition of 1.0 ml deionized water and
the disrupted cells were collected using a rubber policeman.
The suspension containing the disrupted cells was placed into a
microcentrifuge tube with 0.25 ml 4 N perchloric acid and
centrifuged using a microcentrifuge (Model 5413, Eppendorf,
Brinkmann Instruments Inc., Westbury, New York, USA). The
radioactivity of supernatants was counted using a liquid scintil-
lation counter (Tri-Carb 460C, Packard, Downers Grove, Illi-
nois, USA). The protein of pellets was measured by the method
of Lowry et al [27].
Cellular 45Ca2 efflux
The cells were washed twice with 2 ml PSS or 110 mM
([Na]e solution and then were incubatel with 2 ml PSS or 110
+ 45m [Na ]e solution containing 2 pCi/mI Ca (ICN) for 60
minutes at 37°C. At the end of the incubation, the cells were
rapidly rinsed ten times during one minute with 2 ml PSS or 110
mM [Na] solution. The medium was placed into a counting
vial and replaced with 2 ml PSS or 110 ms [Nale solution at
each minute from one to six minutes. PSS or 110 mrs'i [Na}
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Fig. 1. Polentiating effect of decreases in
ext racellular Na ([Na]) concentration on
intracellular 45Ca2 uptake in rat VSMC. The
cells were incubated with different
concentrations of [Na}e concentration
0 supplemented by choline chloride for 60
minutes at 37°C. Values are expressed as
mean SEM, N = 6.
Table 1. Dose-dependent effect of AVP or PMA on the cellular contractile response in rat VSMC
Cel1 contraction %
Vehicle lx 109M lx 108M 1 xl0 lxl06M 1X105M
AVP 1.8 9.2 15.1 21.5 27.2 25.2i.i 1.1° 1.2a Ø9 l.2a 0.6a
PMA 2.0 9.7 13.8 20.7 34.7 37.7
1.2 1.5° 1.2a 0.8° 2.3a 34
Values are expressed as mean SEM, N = 6.
P < 0.01 vs. vehicle.
solution (2 ml) with or without 10—8 M or 10—6 M AVP was
added at six minutes into the time course of 45Ca2 efflux
studies and samples were collected for five additional one-
minute periods. Intracellular radioactivity was extracted with 2
ml sodium dodecyl sulfate (SDS)-alkaline solution (0.1% SDS
and 0.1 N NaOH) and measured using a liquid scintillation
counter. The results were expressed as percent of release from
the resting intracellular 45Ca2 counts at the measured time.
AVP receptor binding study
After the cells were washed twice with 2 ml PSS, they were
incubated with 2 ml PSS or 110 mivi [Na]e solution for 60
minutes at 37°C. At the end of the incubation the cells were
washed twice with 2 ml ice-cold PSS or 110 mM [Na]e solution
and then incubated with 2 ml ice-cold PSS or 110 mM [Na]e
solution containing 0.1% bovine serum albumin and 2 x lO M
3H-AVP (specific activity, 67.7 Cilmmol, New England Nu-
clear, Wilmington, Delaware, USA) in the presence or absence
of 1 x 106 M AVP at 4°C for 60 minutes. The cells were rinsed
four times with 2 ml ice-cold PSS or 110 mvi [Na]e solution
and then were dissolved with 2 ml SDS-alkaline solution.
Samples (100 d) were stored at 4°C for protein assay by the
method of Lowry et al [271 and the radioactivity of samples was
counted using a liquid scintillation counter.
Measurement of inositol phosphate
As described previously [19, 21], the cells were washed twice
with 2 ml inositol-free Dulbecco's modified MEM (DMDM)
(Hazleton Research Products Inc.) and incubated for two days
with 1.5 ml inositol-free DMEM containing 5 CiIml myo-2[3H]
inositol (specific activity, 19 Ci/mmol; Amersham Co., Arling-
ton Heights, Illinois, USA) at 37°C in a humidified atmosphere
of 95% air/5% CO2. At the beginning of the experiment the cells
were washed twice with 2 ml PSS or 110 mM [Na]e solution for
10 minutes at 37°C. At the end of the incubation the cells were
covered for 10 seconds at 37°C with 1 ml PSS or 110 mri [Na]e
solution with or without 10_8 M or 10—6 M AVP. The reaction
was stopped by the addition of 100 d ice-cold 100% trichloro-
acetic acid. The cells were then scraped using an Eppendorf
pipette tip and the suspension containing the disrupted cells was
centrifuged using a microcentrifuge. The supernatant was
washed four times with 3 ml ice-cold ether, adjusted to pH 7.0
using 1 M Tris-base and stored at —20°C until analysis. The
pellets were dissolved with 1 ml 0.1% SDS-alkaline solution and
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stored at 4°C for protein assay. The water-soluble fractions
were applied to columns consisting of I ml of Dowex (1-x8,
formate form) and serially eluted with distilled H20, Borax [5
mM disodium tetraborate (Sigma), 60 m sodium formate
(Sigma)], and 0.2, 0.5 and 1.0 M ammonium formate (Sigma) in
0.1 M formic acid. This extraction procedure separated inositol,
glycerophosphatidylinositol, inositol- 1-phosphate, inositol bis-
phosphate (1P2), and inositol trisphosphate (1P3); the 1P3 frac-
tion includes 1,3,4- and 1,4,5-1P3 and 1,3,4,5-inositol phos-
phate. The extraction procedure has been previously validated
in our laboratory with radioactive phosphoinositides. The sam-
ples were collected in scintillation vials and counted using a
liquid scintillation counter. Results were expressed as a percent
of the 1P3 and 1P2 production as compared with the basal
intracellular 1P3 and 1P2 concentrations.
Statistical analysis
All results were expressed as the mean 5EM. The unpaired
Student's t-test and an analysis of multiple variance using
Scheffe's method were used for statistical comparison. A P
value of less than 0.05 was considered significant.
Results
Effect of reduced [Na ]e intracellular 45Ca2+ uptake in rat
VSMC
The potentiating effect of decreases in [Na]e concentration
on intracellular 45Ca2 uptake is depicted in Figure 1. The cells
were incubated with different concentrations of [Nafle supple-
mented with choline chloride to maintain the osmolality for 60
minutes at 37°C. The intracellular 45Ca2 uptake was signifi-
cantly increased in the cells preincubated with the 110 m or
lower [Na'je solution as compared with the physiological
condition, 140 mrtx [Nafle. An increase in intracellular 45Ca2
uptake in the cells treated with 110 mrt't [Nafle was observed at
10 minutes after the incubation and was maintained for 60
minutes (data not shown). The following studies were therefore
performed by using the cells preincubated with 110 mrvi [Naje
for 60 minutes to examine the effects of the reduction of [Na]
within a clinical range on the vascular action of AVP in VSMC.
Effect of 110 mw [Na]e on cellular contractile response
induced by AVP, PMA and OAG
The incubation of the cells with AVP for 10 minutes increased
the cellular contractile response of VSMC in a dose-dependent
manner (Table 1). The potentiating effect of the 110 mt [Na]e
solution on the cellular contractile response of VSMC to AVP is
demonstrated in Figure 2. The preincubation of the cells with
the 110 mrvi [Na] solution supplemented with 30 mrvi choline
chloride for 60 minutes at 37°C did not affect the basal cell
volume changes (data not shown) but significantly enhanced the
I X i0 M, but not 1 x 10—6 M, AVP-induced cellular
contractile response of VSMC.
The possible role of PKC in the mechanism of 110 mrvi [Nat]
to enhance the AVP-induced cellular contractile response was
studied by examining the effect of 110 mrvi [Nafl on the cellular
contractile response to PMA and OAG. The incubation of the
cells with PMA for 10 minutes induced the cellular contractile
response in a dose-dependent manner (Table 1). The cellular
contractile respOnse was not observed using an inactive phorbol
ester [18, 28]. The preincubation of the cells with the 110 mM
[Na'je solution for 60 minutes enhanced the 1 x 10_8 M, but not
1 x lO_6 NI, PMA-induced cellular contractile response (Fig. 3).
The similar results were obtained in the cellular contractile
response induced by 1 x 10_s M OAG (vehicle, 2.0 1.3% vs.
2.4 1.2%, N 4; 1 x l0_8 M OAG, 13.1 1.8% vs. 18.4
1.4%, N = 4, P C 0.05). This potentiating effect of 110 m
[Na4j on the 1 x 10—8 M OAG-induced cellular contractile
response was not present in the cells preincubated with the
Ca2-free 110 mrvi [Na] solution containing 0.1 mrts EGTA
(vehicle, 0.6 1.0% vs. 0.5 0.6%; 1 x io M OAG, 5.4
0.9% vs. 4.5 0.6%, N = 4, NS). The following studies were
performed to examine the cellular mechanisms of 110 m
[Na]e to enhance the AVP-induced cellular contractile re-
sponse of VSMC.
Effect of110 mv [Na]e on A VP-induced increase of [Ca2t],
The preincubation of the cells with the 110 m [Naje
solution for 60 minutes increased the basal [Ca2] and poten-
tiated the submaximal, but not maximal, doses of AVP-induced
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Fig. 2, Potentiating effect of 110 mvt [NaJ on A VP-induced cellular
contractile response in rat VSMC. Symbols are; 140 mM lNa]e (open
bars) and 110 ms [NaJ (solid bars). Values are expressed as mean
5EM, N = 5.
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Fig. 3. Potentiating effect of 110 msi [Na on PMA -induced cellular
contractile response in rat VSMC. Symbols are; 140 msi [Na]e (open
bars) and 110 mrsi [NC]e (solid bars). Values are expressed as mean
5EM, N = 5.
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Fig. 5. The effect of 110 mic [Na7 on maximal changes in AVP-
induced increase in [Ca2], in rat VSMC. Symbols are: 140 mri [Na]e
(open bars) and 110 mrvi [Na] (solid bars). Values are expressed as
mean SEM, N = 5. *J <0.01.
Fig. 4. Potentiating effect of i/O mM[Na7
on I X 10 MAVP-induced increase in
[Ca27, in rat VSMC. Symbols are: 140 mM
[Na]e (dashed line) and 110 mst [Na]e (solid
3 line). Values are expressed as mean SEM,
N = 5. < 0.05, < 0.01 vs. 140 mM
[Na]e.
**
**
**
**
I- I
**
**
AVP (10M)
C0
Ct
C
a)0C00
E
Ct0
a)
a)
o
0(00
0
C0
Ct
C
a)0C0
C.)
E
C.)
(U
C)
a)
a)
o
0(00
>.0
** **
400
300
200
100
0
600
500
400
300
200
100
0
0 1 2
Time, minutes
9 8
-log[AVP], M
AVP-induced increase in [Ca2i were completely abolished in
the cells preincubated with the Ca2-free 110 mr't [Na]
solution containing 0.1 mM EGTA for 60 minutes (Table 2).
Effect of 110 m [Na on [Na
The basal [Na]1 of rat VSMC was rapidly decreased by
changing from 140 mivi [Na]e to the 110 mM [Na]e (Fig. 6),
and gradually recovered but remained lower in 110 mivi [Na]e
than in 140 mr'vi [Na] during 60 minutes of incubation (13.4
0.6 vs. 6.8 0.8 mM, P <0.01, N = 4).
Effect of 110 mM [Na] on A VP-produced 45Ca2 efflux
6 Since the AVP-induced increase in Ca2 efflux modulates theAVP increased [Ca2]1, the effect of 110 mr'i [Na]e on the
AVP-produced 45Ca2 efflux was examined to study whether a
change in Ca2 efflux is associated with the effect of 110 mM
[Na}e to increase basal and AVP increased [Ca2]1. The
preincubation of the cells with the 110 mM [Na]e solution for
60 minutes increased the basal and 1 x 10—8 M, but not 1 x 10_6
M, AVP-produced 45Ca2 efflux (Table 3). This result indicates
that an increase in the basal and AVP increased [Ca2]1 by 110
mM [Na1 did not result from a decrease in the transmembrane
Ca2 efflux.increase of [Ca2]1 (Table 1, Figs. 4 and 5). The enhancing effectof 110 mM [Na]e on the AVP increased [Ca2] was most
pronounced at the lower concentrations of AVP. The basal
[Ca211 was higher in the 110 m [Nale media. Moreover, the
increment in [Ca2 l with submaximal doses of AVP was larger
in the 110 mrvi [Na]e than the 140 m media. However, there
were no differences between the groups in the percent increase
of [Ca2]1 induced by submaximal doses of AVP from their
respective basal values. Since the AVP-induced increase in
[Ca2]1 consists of an increase in Ca24 uptake and the release of
Ca2 from the intracellular Ca2 stores, the effect of Ca2-free
110 mM [Na]e solution on this potentiation of the basal and
AVP increased [Ca2]1 by 110 mr'i [Nale was examined. The
increasing effects of 110 mrvi [Nal on the basal [Ca2], and
Effect of 110 mM [Na] on AVP binding to receptors
The binding of 2 x i0 M 3H-AVP to the receptors of VSMC
at 4°C was displaced by cold AVP and the structural AVP V1
antagonist, [1-(/3-mercapto-/3,/3-cyclopentamethylenepropionic
acid), 2-(O-methyl)-tyrosine] AVP [d(CH2)5Tyr(Me)AVP] [29].
The non-specific binding of 2 x iO M 3H-AVP at 4°C
determined in the presence of 1 x 106 M AVP was approxi-
mately 30% of total binding. Scatchard analysis, obtained by
the incubation of the cells with 2 x io M 3H-AVP for 60
minutes at 4°C, revealed a single class of surface binding sites,
and 110 mivi [Nale did not affect the Kd (2.50 x l0'° vs. 2.28
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X 10—10 M, N = 3, NS) or Bmax (218 vs. 229 fmollmg protein,
N = 3, NS) of these receptors.
Effect of 110 ms'i [Na] on A VP-stimulated inositol
phosphate production
The incubation of the cells with AVP for 10 seconds in-
creased 1P3 production (vehicle, 100.0 1.8%; 1 x 10—8 M,
127.5 2.8%*; 1 x 10 M, 167.4 4,9%*; I x 10—6 M, 237.5
6.5%*; tP < 0.01 vs. vehicle, N 4) and 1P2 production(vehicle, 100.0 9.1%; 1 x l0 M, 154.7 55%*; I x 10 M,
278.3 9.3%*; 1 x 10—6 M, 472.8 15.0%*; C 0.01 vs.
vehicle, N = 4). The preincubation of the cells with the 110mM
[Na'J9 solution for 60 minutes did not change the basal 1P1 and
1P2 levels or the 1P3 and 1P2 production in response to 1 x 10_B
M and 1 x 10_s M AVP (Fig. 7).
Discussion
Previous studies have shown that after binding to the V1
receptor AVP activates phospholipase C to produce two differ-
ent intracellular second messengers: 1P5 and diacylglycerol
(DAG) [19, 30—34]. This rapid increase in DAG is followed by
the sustained production of DAG as a result of phospholipase C
and D-induced hydrolysis of phosphatidylcholine [34]. 1P3
increases Ca2 from the intracellular Ca2 stores and increases
[Ca2"j1; this is associated with an increase in cellular Ca2'
uptake and initiation of the contractile response [19, 30, 33, 35,
36]. Ca2 efflux is also stimulated by AVP with a resultant
decrease in [Ca2]1 toward the basal level within a few minutes
[19, 37]. Moreover, DAG activates PKC which is involved in
the maintenance of the cellular contractile response [18, 35, 36,
381.
The present results indicate that the preincubation of the cells
with the 110 m [Na19 solution for 60 minutes potentiates the
cellular contractile response to AVP by enhancing both the
Ca2/calmodulin-mediated branch which triggers the cellular
contractile response and the DAG/PKC branch which maintains
the cellular contractile response [35, 36]. The experimental
evidence from the present study which supports this conclusion
involves the following observations. The preincubation of the
110 mri [Nat]9 solution for 60 minutes increased the basal
[Ca2} level and potentiated the submaximal doses of AVP to
increase [Ca2t]1, and to regulate the Ca2t/calmodulin branch
mediated through an increase in cellular Ca2' intake. This 110
mM [Na"] enhanced the sustained cellular contractile response
to submaximal doses of AVP and PKC activators (PMA and
OAG). The Ca2"-free state completely inhibited the effects of
110 mrs [Na4']9 solution on [Ca2"]1 and the cellular contractile
response.
The effects of 110 mrs [Na'19 on [Na"]1, the transmembrane
Ca2t movement, AVP binding to the receptors and AVP-
induced 1P3 production were examined to reveal the cellular
mechanisms of 110 mrs [Na]9 solution to enhance the vascular
action of AVP. The results demonstrated that 110 mrs [Na]9
decreased [Na]1 and increased intracellular 45Ca2"' uptake, the
AVP-stimulated 45Ca2 efflux and the basal and submaximal
doses of AVP increased [Ca2"]1. The preincubation of the cells
Table 2. Effect of extracellular Ca2" concentration ([Ca2"]e) on an increase in basal [Ca2t]1 and maximal change in AVP-induced increase in
[Ca2"']1 by 110 mM extraccllular Na" concentration ([Na"']9) in rat VSMC
Basal [Ca2]1 nM
Maximal changes in 1 x l0- M AVP-induced
increase in [Ca2"']1 nM
140mM 110mM 140mM 110mM
[Ca2"]9 [Nat]9 [Na"]9 P value [Nat]9 [Nat]9 P value
2 ms'i 89.3
7,4
152.7
17.0 <0.01
293.4
12.2
436.3
17.2 <0.01
0 mM 39.1
2.3
43.6
NS
126.5
19.0
128.6
24.1 NS
P value <0.01 <0.01 <0.01 <0.01
Values are expressed as mean SCM, N = 6.
20
10 -
5-
[Na÷]9
(110mM)
0 5 10 15 20 Fig. 6. Effect of 110 mM [Na"]9 on [Na']9
rat VSMC. Arrow shows the change from
in
140
Time, minutes to 110 m [Na"']9.
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Table 3. Potentiating effect of 110 mt lNa] on basal and AVP-stimulated 45Ca2 effiux in rat VSMC
Time mm
Basal AVP (10-8 M) AVP (106 M)
1 2 3 1 2 3i 2 3
140 mi [Na]e
110mM [Na]
3.82
0.03
4.74
0.14
3.88
0.03
4.90
o.is
3.82
0.03
4.72
o.l2
17.89
0.63
20.12
O.47a
27.58
0.28
31.56
0.46a
18.70
0.48
20.50
0.66a
31.39
0.33
31.82
0.30
33.25
0.58
33.94
0.54
20.33
0.42
19.65
0.35
Values (% release from resting intracellular 45Ca2 counts) are expressed as mean SEM, N = 5. Time indicates minutes after the addition of
AVP.
a P < 0.01 vs. 140 mM[Na]e
with the Ca2-free 110 mrt [Na]e solution for 60 minutes
depleted the intracellular Ca2 stores and completely inhibited
cellular Ca2 uptake. The Ca2-free 110 mM [Na}e solution
also completely abolished the potentiating effect of 110 mM
[Na]e on the basal and AVP increased [Ca21j1. The preincu-
bation of the cells with the 110 mM [Na1e solution for 60
minutes did not alter the binding of 3H-AVP to the receptors or
the AVP-induced production of 1P3. These findings in VSMC
indicate that the potentiating effect of 110 mrvi [Na]e on the
AVP-induced increase in 1Ca2j, is dependent on an increase in
cellular Ca2 uptake. The reduction of [Na]e has been shown
to activate the Na/Ca2 exchange with a resultant increase in
Ca2 uptake and Na efflux, thus maintaining the transmem-
brane Na gradient in VSMC and other tissues [15—171. The
reduction of [Na]e is suggested to inhibit the activity of
Na/K-ATPase and induce the depolarization of the cell
membrane with subsequent activation of voltage-dependent
Ca2 channels. Taken together, the potentiating effect of 110
mM [Na] on the basal and AVP-induced increase in [Ca2]1
may be associated with the activation of both NaICa2 ex-
change and voltage-dependent Ca2 channels.
The activation of PKC appears to be important in the
maintenance of cellular contractile response [35, 36, 39—43]. In
this regard, recent studies in cultured rat VSMC from our
laboratory demonstrated that two different phorbol esters,
PMA and dioctanoylglycerol, caused the cellular contractile
response but an inactive phorbol ester did not [18, 28]. There-
fore, the role of PKC in the mechanism of 110 mtvt [Na]e to
enhance the AVP-induced cellular contractile response was
studied by examining the effect of 110 mrs [Na] on the cellular
contractile response to PMA and OAG. It has been known that
phorbol esters increase the affinity of PKC for [Ca2]1 so that
PKC is activated at basal [Ca2]1 concentration [44—47]. In the
present study the preincubation of the cells with the 110 mr't
[Na]e solution for 60 minutes stimulated the cellular Ca2
uptake to increase the basal [Ca2J to a concentration similar to
the peak levels in the I X io— M AVP increased [Ca2]1. The
preincubation of the cells with the 110mM [Na]e solution for
60 minutes also enhanced the submaximal doses of PMA- and
OAG-induced cellular contractile response. The Ca2-free 110
mM [Na], solution completely abolished this enhancing effect
of 110 mM [Na]e on the OAG-induced cellular contractile
response as intracellular Ca2 stores and Ca2 uptake decrease.
Thus, an increase in the basal [Ca2], mediated through the
activation of cellular Ca2 uptake appears to enhance the
activity of PKC and potentiate the cellular contractile response
to PMA and OAG.
In conclusion, the present results suggest that a reduced
C0
C.)
V0
0.
a)
ce
0.
C',00
0
Cl)0C
A Inositol triphosphate (1P3) B Inositol biphosphate (lP2)
400
300
200
100
0
Basal AVP AVP
(10M) (10AM)
Fig. 7. Effect of 110 mM [Na] on AVP-
induced production of!P2 and 1P3 in rat
Basal AVP AVP VSMC. Symbols are: 140 msi [Na] (open
bars) and 110 mi [Na] (solid bars). Values
(10AM) (106M) are expressed as mean SEM, N = 5.
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[Na]e may increase in cellular Ca2 uptake, and enhance the
VSMC contractile response to AVP by potentiating the AVP-
induced increase in [Ca2]1 and the activity of PKC. Thus, the
vascular effect of the non-osmotic release of AVP may be
enhanced in clinical states with severe hyponatremia.
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